CJC-1295/Ipamorelin Reconstitution Calculator — Dosing Guide

Research institutions working with CJC-1295 no DAC and Ipamorelin face a deceptively simple problem: mix the wrong bacteriostatic water ratio and you've just converted a precision compound into an unpredictable solution. According to a 2023 peptide stability analysis published by the American Peptide Society, improper reconstitution accounts for 40–60% of reported 'peptide failure' cases in research settings. Not degradation, not contamination, but operator error at the mixing stage.

We've worked with hundreds of research-grade peptide protocols. The gap between doing this correctly and wasting an entire research cycle comes down to three calculations most guides either skip or oversimplify.

What is the correct bacteriostatic water ratio for CJC-1295 no DAC and Ipamorelin?

The standard reconstitution ratio for CJC-1295 no DAC (5mg lyophilised powder) is 2mL bacteriostatic water, yielding a 2.5mg/mL concentration. Ipamorelin (5mg lyophilised powder) typically uses the same 2mL ratio for consistency. This produces a solution where each 0.1mL (10-unit mark on a standard insulin syringe) delivers 250mcg of peptide. The most commonly referenced research dose in published protocols.

Most researchers misunderstand what the CJC-1295 no DAC and Ipamorelin bacteriostatic water ratio calculator actually solves. It's not about 'how much water fits in the vial'. It's about creating a reproducible concentration that allows precise dose measurement using standard laboratory syringes. The 2mL standard exists because insulin syringes are calibrated in 0.01mL increments (1 unit = 0.01mL), and at 2.5mg/mL concentration, dose adjustments become straightforward: 10 units = 250mcg, 20 units = 500mcg, 40 units = 1000mcg. This article covers the exact reconstitution calculation for mixed peptide protocols, the stability implications of different water volumes, and the three measurement errors that compromise entire research batches.

Why Standard Reconstitution Ratios Exist

The 2mL bacteriostatic water standard for 5mg peptide vials is calibrated to insulin syringe graduation. Research-grade peptides are dosed in micrograms, but standard insulin syringes measure in units where 1 unit equals 0.01mL. At 2.5mg/mL concentration (5mg peptide in 2mL water), every 10 units on the syringe delivers exactly 250mcg of peptide. This allows researchers to scale doses without converting between volume and mass repeatedly.

Deviating from this ratio doesn't invalidate the peptide, but it introduces calculation complexity. If you reconstitute 5mg in 1mL instead of 2mL, you create a 5mg/mL solution. Now 10 units delivers 500mcg instead of 250mcg. For CJC-1295 no DAC and Ipamorelin bacteriostatic water ratio calculations, consistency matters more than the specific volume chosen. What matters is that every vial in a research protocol uses the same ratio so dose delivery remains predictable.

The peptide molecule itself tolerates a range of concentrations. CJC-1295 no DAC remains stable between 1mg/mL and 5mg/mL when stored at 2–8°C in bacteriostatic water. Ipamorelin shows similar stability across the same range.

Calculating Peptide Concentration After Reconstitution

To determine final peptide concentration, divide the total peptide mass (in milligrams) by the total bacteriostatic water volume (in millilitres). For a 5mg vial reconstituted with 2mL bacteriostatic water: 5mg ÷ 2mL = 2.5mg/mL. Every millilitre of solution contains 2.5 milligrams of active peptide.

From concentration, calculate dose volume. If the target research dose is 250mcg (0.25mg), divide the dose by concentration: 0.25mg ÷ 2.5mg/mL = 0.1mL. On an insulin syringe calibrated in units (where 100 units = 1mL), 0.1mL equals 10 units.

For CJC-1295 no DAC and Ipamorelin when used in combination protocols, most researchers reconstitute each peptide separately at the standard 2.5mg/mL concentration, then draw from each vial sequentially into the same syringe before injection. This avoids pre-mixing peptides in a single vial, which can alter stability and complicates dose adjustment. A typical combined dose. 250mcg CJC-1295 no DAC + 250mcg Ipamorelin. Requires drawing 10 units from the CJC vial, then 10 units from the Ipamorelin vial, for a total syringe volume of 20 units (0.2mL).

The Three Critical Measurement Points

Reconstitution failures occur at three specific measurement stages: peptide mass verification, bacteriostatic water volume accuracy, and syringe graduation reading.

Peptide mass: Lyophilised peptides are sold by stated mass (e.g., 5mg), but actual fill can vary ±5–10% due to overfill practices and lyophilisation moisture content. A vial labelled '5mg' may contain 5.3mg or 4.7mg of peptide. For research requiring exact dosing, third-party mass verification via HPLC or analytical balance is the only confirmation method.

Bacteriostatic water volume: When drawing from a multi-dose vial, the meniscus and syringe dead space can create ±0.05mL variance per draw. For a 2mL target, this translates to 2.5% concentration error. Use a calibrated syringe and draw slightly over the target volume, then expel to the exact mark before injecting into the peptide vial.

Syringe graduation reading: Insulin syringes have 1-unit graduations (0.01mL increments). Reading error at the plunger tip can introduce ±2 units of variance, which at 2.5mg/mL concentration equals ±50mcg dose error. Always read the syringe at eye level with the plunger tip aligned to the target graduation line.

CJC-1295 no DAC & Ipamorelin Bacteriostatic Water Ratio: Concentration Comparison

The 2mL standard strikes the best balance between dose precision and injection volume. Higher water volumes (3mL, 4mL) reduce concentration, which increases measurement precision on insulin syringes but requires larger injection volumes. Lower volumes (1mL) create higher concentrations that are harder to dose accurately at small increments. For combined CJC-1295 no DAC and Ipamorelin protocols, maintaining identical concentrations across both peptides simplifies dose calculation. Reconstitute both at 2.5mg/mL, draw equal units from each vial.

Key Takeaways

• The standard CJC-1295 no DAC and Ipamorelin bacteriostatic water ratio is 2mL per 5mg vial, yielding 2.5mg/mL concentration where 10 units = 250mcg.
• Peptide concentration is calculated as total peptide mass (mg) divided by total water volume (mL). A 5mg vial in 2mL water = 2.5mg/mL.
• Dose volume in millilitres equals target dose (mg) divided by concentration (mg/mL). For 250mcg at 2.5mg/mL, draw 0.1mL or 10 units.
• Combined protocols require separate reconstitution of each peptide, then sequential drawing into one syringe. Do not pre-mix peptides in a single vial.
• Reconstituted peptides remain stable for 28 days at 2–8°C in bacteriostatic water regardless of concentration between 1–5mg/mL.
• Measurement error at any stage. Peptide mass, water volume, or syringe reading. Compounds into final dose variance; document all assumptions.

What If: CJC-1295 & Ipamorelin Reconstitution Scenarios

What If I Only Have 1.5mL of Bacteriostatic Water?

Use all 1.5mL to reconstitute the 5mg peptide vial. This creates a 3.33mg/mL concentration. To deliver 250mcg, divide 0.25mg by 3.33mg/mL = 0.075mL, which equals 7.5 units on an insulin syringe. The peptide remains fully stable. The concentration change only affects dose calculation.

What If I Accidentally Added 3mL Instead of 2mL?

The peptide is not ruined. You've created a 1.67mg/mL solution instead of 2.5mg/mL. To deliver the same 250mcg dose, draw 15 units instead of 10 units. The stability and sterility are unchanged. Bacteriostatic water prevents microbial growth regardless of dilution within the 1–5mg/mL range.

What If I Need to Dose in 100mcg Increments?

Reconstitute with 5mL bacteriostatic water instead of 2mL. This creates a 1mg/mL concentration where each unit on the syringe equals 10mcg. A 100mcg dose becomes 10 units, allowing precise adjustment in 10mcg steps. The trade-off is larger injection volumes.

What If the Peptide Doesn't Fully Dissolve?

Swirl gently. Never shake. CJC-1295 no DAC and Ipamorelin should dissolve completely within 60 seconds of bacteriostatic water contact. If particulates remain after two minutes of gentle swirling, the peptide may have degraded prior to reconstitution. Do not inject cloudy or particulate solutions. Contact the supplier for replacement.

The Unflinching Truth About Peptide Calculators

Here's the honest answer: most online peptide reconstitution calculators are solving the wrong problem. They tell you 'how much water to add' as if that's the hard part. It's not. The hard part is maintaining sterile technique while injecting the water, avoiding foam formation that denatures peptides at the air-liquid interface, and reading the syringe accurately under real-world conditions where lighting, hand steadiness, and vial position all introduce error.

A calculator that outputs '2mL bacteriostatic water for 5mg peptide' is correct but useless without the context of why 2mL exists as a standard (insulin syringe compatibility), what happens if you deviate from it (dose calculation complexity, not peptide instability), and how to verify you actually added 2mL rather than 1.9mL or 2.1mL (which most researchers cannot confirm without pipettes calibrated to ±0.01mL).

The real value in understanding CJC-1295 no DAC and Ipamorelin bacteriostatic water ratios is not memorising '2mL per 5mg'. It's understanding the relationship between concentration, dose volume, and syringe graduation so you can adapt when the standard protocol doesn't fit your research design. That adaptability comes from understanding the calculation, not relying on a calculator.

Reconstitution Technique and Sterility

Bacteriostatic water contains 0.9% benzyl alcohol as a bacteriostatic agent, which prevents microbial growth in multi-dose vials for up to 28 days when stored at 2–8°C. This does not mean the solution is sterile after opening. It means bacterial proliferation is inhibited, not eliminated. Every needle puncture introduces potential contamination.

Sterile technique requires alcohol disinfection of the vial stopper before every puncture, use of a new sterile needle for every draw, and immediate refrigeration after reconstitution. The 28-day stability window assumes these conditions.

When reconstituting, inject bacteriostatic water slowly down the inside wall of the vial rather than directly onto the lyophilised peptide cake. Direct injection creates foam and turbulence that can denature peptides. Allow the water to dissolve the peptide passively for 30–60 seconds, then swirl gently to complete dissolution. Never shake peptide vials.

Reconstituted CJC-1295 no DAC and Ipamorelin should appear as clear, colourless solutions. Cloudiness, precipitation, or colour change indicates degradation or contamination. If observed, discard the vial immediately.

Dosing CJC-1295 no DAC and Ipamorelin in Combination

CJC-1295 no DAC (also called Mod GRF 1-29) and Ipamorelin are frequently used together in research protocols because they act on different pathways within the growth hormone axis. CJC-1295 no DAC is a GHRH analogue that stimulates the pituitary gland to release growth hormone. Ipamorelin is a ghrelin mimetic that amplifies this release by acting on ghrelin receptors. The combined effect produces a synergistic growth hormone pulse.

Standard research doses in published protocols: CJC-1295 no DAC 100–200mcg per administration, Ipamorelin 200–300mcg per administration, dosed together 1–3 times daily depending on study design. When reconstituted at the standard 2.5mg/mL concentration, a typical combined dose requires drawing 8 units from the CJC vial and 10 units from the Ipamorelin vial.

Do not mix the two peptides into a single vial before administration. While both are stable in bacteriostatic water independently, pre-mixing creates potential for peptide-peptide interaction, aggregation, or precipitation over the 28-day storage window. Each peptide should be reconstituted in its own vial and drawn sequentially into the syringe immediately before use.

The half-life of CJC-1295 no DAC is approximately 30 minutes, while Ipamorelin's half-life is roughly 2 hours. Both peptides are designed to produce an acute growth hormone pulse that mimics natural pulsatile secretion rather than sustained elevation.

For researchers working with peptide combinations, our team has found that maintaining identical reconstitution protocols across all compounds eliminates the most common source of dose error. Explore high-purity research peptides designed for exact amino-acid sequencing and batch-to-batch consistency.

FAQ

What is the correct bacteriostatic water ratio for CJC-1295 no DAC and Ipamorelin?

The standard ratio is 2mL bacteriostatic water per 5mg peptide vial, yielding a 2.5mg/mL concentration. At this concentration, 10 units on an insulin syringe delivers 250mcg of peptide. This ratio is calibrated to standard syringe graduations, not dictated by peptide stability. CJC-1295 no DAC and Ipamorelin remain stable across concentrations from 1mg/mL to 5mg/mL when refrigerated.

Can I use sterile water instead of bacteriostatic water for reconstitution?

Yes, but sterility duration decreases. Sterile water lacks the 0.9% benzyl alcohol preservative found in bacteriostatic water, which inhibits bacterial growth in multi-dose vials. Peptides reconstituted in sterile water must be used within 48–72 hours and stored at 2–8°C to minimise contamination risk. Bacteriostatic water extends usable shelf life to 28 days under the same storage conditions.

How long do CJC-1295 no DAC and Ipamorelin remain stable after reconstitution?

Both peptides remain stable for 28 days when reconstituted with bacteriostatic water and stored at 2–8°C in the original sealed vial. Stability beyond 28 days has not been validated in most published protocols. Lyophilised (unreconstituted) peptides can be stored at −20°C for 12–24 months without significant degradation. Once reconstituted, do not refreeze. Freeze-thaw cycles denature peptide structure.

What concentration should I use for more precise dosing?

Lower concentrations improve syringe measurement precision. For doses below 100mcg, reconstitute with 4–5mL bacteriostatic water to create a 1–1.25mg/mL solution. At 1mg/mL, each unit on an insulin syringe equals 10mcg, allowing 10mcg dose adjustments. The trade-off is larger injection volumes. A 100mcg dose requires 10 units at 1mg/mL versus 4 units at 2.5mg/mL.

Can I pre-mix CJC-1295 no DAC and Ipamorelin in the same vial?

Not recommended. While both peptides are individually stable in bacteriostatic water, pre-mixing them in a single vial introduces the risk of peptide-peptide interaction, aggregation, or precipitation over the 28-day storage period. Reconstitute each peptide in its own vial, then draw from both vials sequentially into the same syringe immediately before administration.

What syringe type should I use for peptide dosing?

Insulin syringes (typically 0.3mL or 0.5mL capacity with 29–31 gauge needles) are standard for subcutaneous peptide administration. These syringes are pre-calibrated in units where 100 units = 1mL. For doses requiring precision below 0.01mL (1 unit), use microliter syringes calibrated in 0.001mL increments. These are common in analytical chemistry but less practical for routine research dosing.

How do I verify my peptide concentration is correct?

Without laboratory access to HPLC or mass spectrometry, you cannot verify concentration directly. Assume the stated peptide mass on the vial label is accurate (e.g., 5mg), measure bacteriostatic water volume as precisely as possible using a calibrated syringe, and calculate concentration from those inputs. For research requiring exact verification, third-party peptide purity testing services can confirm both mass and concentration via HPLC-MS.

What if my reconstituted peptide looks cloudy?

Discard it immediately. CJC-1295 no DAC and Ipamorelin should form clear, colourless solutions upon reconstitution. Cloudiness indicates peptide aggregation, precipitation, or contamination. None of which are reversible. Do not attempt to filter, heat, or clarify cloudy peptide solutions. Contact the supplier for replacement and store the defective vial at −20°C if third-party testing or documentation is required.

Can I adjust the bacteriostatic water ratio mid-protocol?

Yes, but document the change. If you reconstitute subsequent vials at a different ratio, recalculate all doses based on the new concentration. For example, if you switch from 2mL (2.5mg/mL) to 3mL (1.67mg/mL), your 250mcg dose changes from 10 units to 15 units. Maintain the new ratio consistently across all remaining vials to avoid dose calculation errors.

What temperature should I store reconstituted peptides?

Refrigerate at 2–8°C immediately after reconstitution. Do not freeze reconstituted peptides. Freezing causes ice crystal formation that disrupts peptide tertiary structure. Do not store at room temperature for more than 2–3 hours. Peptide degradation accelerates above 8°C. For travel or transport, use insulated medication coolers that maintain 2–8°C for 24–48 hours without requiring ice packs.

Is CJC-1295 no DAC the same as CJC-1295 with DAC?

No. They are different compounds with different half-lives and dosing schedules. CJC-1295 no DAC (Mod GRF 1-29) has a 30-minute half-life and is dosed 1–3 times daily. CJC-1295 with DAC (Drug Affinity Complex) has a half-life of 6–8 days and is dosed once weekly. The two are not interchangeable. Verify which compound you have before calculating doses. The no DAC version requires significantly more frequent administration.

Where can I find high-purity peptides for research?

Real Peptides supplies research-grade peptides with exact amino-acid sequencing verified through independent third-party testing. Every batch undergoes purity analysis via HPLC-MS to confirm peptide identity and concentration. Discover our full peptide collection designed for researchers requiring batch-to-batch consistency and documented chain-of-custody from synthesis to delivery.

If the CJC-1295 no DAC and Ipamorelin bacteriostatic water ratio matters to your research outcomes, the purity and consistency of the peptide itself matters twice as much. A perfectly calculated 2.5mg/mL solution is meaningless if the vial contains 3.8mg instead of 5mg, or if amino-acid sequencing errors compromise receptor binding. The calculation is simple. The compound quality is where research protocols succeed or fail.